WO2007033369A3 - Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes - Google Patents
Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes Download PDFInfo
- Publication number
- WO2007033369A3 WO2007033369A3 PCT/US2006/036007 US2006036007W WO2007033369A3 WO 2007033369 A3 WO2007033369 A3 WO 2007033369A3 US 2006036007 W US2006036007 W US 2006036007W WO 2007033369 A3 WO2007033369 A3 WO 2007033369A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- platelets
- measuring
- assessing risk
- cerebrovascular thrombosis
- risk
- Prior art date
Links
- 208000007536 Thrombosis Diseases 0.000 title abstract 2
- 206010043647 Thrombotic Stroke Diseases 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/22—Haematology
- G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Test d'évaluation pratique, économique et réactif pour l'évaluation du risque d'accident thrombotique chez un sujet ; plus précisément, il a été établi que les personnes à risque dans le domaine de la thrombose vasculaire cérébrale présentaient un dépôt élevé de C4d sur leurs plaquettes.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71752505P | 2005-09-14 | 2005-09-14 | |
| US60/717,525 | 2005-09-14 | ||
| US52005406A | 2006-09-11 | 2006-09-11 | |
| US11/520,054 | 2006-09-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2007033369A2 WO2007033369A2 (fr) | 2007-03-22 |
| WO2007033369A3 true WO2007033369A3 (fr) | 2007-11-01 |
Family
ID=37865605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2006/036007 WO2007033369A2 (fr) | 2005-09-14 | 2006-09-14 | Evaluation du risque de thrombose vasculaire cerebrale par mesure de c4d sur les plaquettes |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2007033369A2 (fr) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976540A (en) * | 1993-05-17 | 1999-11-02 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| US6312693B1 (en) * | 1998-02-19 | 2001-11-06 | Alejandro A. Aruffo | Antibodies against human CD40 |
| US20020081293A1 (en) * | 1998-02-20 | 2002-06-27 | Tanox, Inc., Delaware Corporation | Inhibitors of complement activation |
| US20020192758A1 (en) * | 2000-08-01 | 2002-12-19 | Welcher Andrew A. | C3b/C4b complement receptor-like molecules and uses thereof |
| US20040077934A1 (en) * | 1999-07-06 | 2004-04-22 | Intercure Ltd. | Interventive-diagnostic device |
| US20050130230A1 (en) * | 2003-09-23 | 2005-06-16 | Antoni Davalos | Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof |
-
2006
- 2006-09-14 WO PCT/US2006/036007 patent/WO2007033369A2/fr active Application Filing
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976540A (en) * | 1993-05-17 | 1999-11-02 | T Cell Sciences, Inc. | Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions |
| US6312693B1 (en) * | 1998-02-19 | 2001-11-06 | Alejandro A. Aruffo | Antibodies against human CD40 |
| US6413514B1 (en) * | 1998-02-19 | 2002-07-02 | Bristol-Myers Squibb Company | Methods of using antibodies against human CD40 |
| US20020081293A1 (en) * | 1998-02-20 | 2002-06-27 | Tanox, Inc., Delaware Corporation | Inhibitors of complement activation |
| US20040077934A1 (en) * | 1999-07-06 | 2004-04-22 | Intercure Ltd. | Interventive-diagnostic device |
| US20020192758A1 (en) * | 2000-08-01 | 2002-12-19 | Welcher Andrew A. | C3b/C4b complement receptor-like molecules and uses thereof |
| US20050130230A1 (en) * | 2003-09-23 | 2005-06-16 | Antoni Davalos | Cellular fibronectin as a diagnostic marker in stroke and methods of use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007033369A2 (fr) | 2007-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007044763A3 (fr) | Systeme et procede permettant la detection de transactions frauduleuses | |
| DK2327792T3 (da) | Fremgangsmåder og sammensætninger til påvisning af autoimmunsygdomme | |
| WO2009087359A3 (fr) | Procédé et système d'évaluation d'activité internet | |
| CR20190574A (es) | Ensayos de diagnóstico para detectar, cuantificar y/o rastrear microbios y otros analitos | |
| WO2008127226A3 (fr) | Antagonistes de kinase p13 | |
| TW200626989A (en) | Multifocal lenses for pre-presbyopic individuals | |
| IN2014DN05011A (fr) | ||
| WO2006066118A3 (fr) | Conditionnement contextuel des peurs pour predire l'efficacite immunotherapeutique | |
| WO2009014787A3 (fr) | Dosage de plusieurs analytes | |
| WO2008122053A3 (fr) | Compositions, kits et procédés correspondants pour la détection et/ou le contrôle de pseudomonas aeruginosa | |
| WO2017070114A3 (fr) | Biomarqueurs associés au diabète et de traitement d'affections associées au diabète | |
| TW200737128A (en) | Systems, methods, and apparatus for detection of tonal components | |
| DE602006021768D1 (de) | Nachweis von lysophosphatidylcholin für die prognose oder diagnose eines systemischen entzündungszustands | |
| WO2008073425A3 (fr) | Dosage grande sensibilité de la protéolyse | |
| WO2009111033A3 (fr) | Détection de biomarqueurs et complexes de biomarqueurs | |
| BRPI0606685A2 (pt) | anticorpos gitr para o diagnóstico de nsclc | |
| EP2312312A3 (fr) | Détection de protéines altérées à conformation et prions | |
| WO2008010837A3 (fr) | Immunodosages non compétitifs pour la détection de petites molécules | |
| WO2007092302A3 (fr) | dispositif d'essai pour la detection d'analytes | |
| HK1232290A1 (zh) | 检测人类骨膜蛋白的新型测定 | |
| GB2585258B (en) | Mass spectrometric method for determining the presence or absence of a chemical element in an analyte | |
| WO2005087793A3 (fr) | Compositions immunostimulatrices et leurs utilisations | |
| WO2008131261A3 (fr) | Biomarqueurs peptidiques de maladie cardiovasculaire | |
| WO2008107570A3 (fr) | Dispositif et procede pour evaluer l'exposition sonore d'un individu | |
| GB2434685B (en) | Method for testing the interconnection of remote hazardous condition detectors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06803661 Country of ref document: EP Kind code of ref document: A2 |